Microbiota Associated With Cholesteatoma Tissue in Chronic Suppurative Otitis Media.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Lausanne : Frontiers Media SA
    • Subject Terms:
    • Abstract:
      Otitis media (OM), defined as infection or inflammation of the middle ear (ME), remains a major public health problem worldwide. Cholesteatoma is a non-cancerous, cyst-like lesion in the ME that may be acquired due to chronic OM and cause disabling complications. Surgery is required for treatment, with high rates of recurrence. Current antibiotic treatments have been largely targeted to previous culturable bacteria, which may lead to antibiotic resistance or treatment failures. For this study, our goal was to determine the microbiota of cholesteatoma tissue in comparison with other ME tissues in patients with long-standing chronic OM. ME samples including cholesteatoma, granulation tissue, ME mucosa and discharge were collected from patients undergoing tympanomastoidectomy surgery for chronic OM. Bacteria were profiled by 16S rRNA gene sequencing in 103 ME samples from 53 patients. Respiratory viruses were also screened in 115 specimens from 45 patients. Differences in bacterial profiles (beta-diversity) and the relative abundances of individual taxa were observed between cholesteatoma and ME sample-types. Additionally, patient age was associated with differences in overall microbiota composition while numerous individual taxa were differentially abundant across age quartiles. No viruses were identified in screened ME samples. Biodiversity was moderately lower in cholesteatoma and ME discharge compared to ME mucosal tissues. We also present overall bacterial profiles of ME tissues by sample-type, age, cholesteatoma diagnosis and quinolone use, including prevalent bacterial taxa. Our findings will be useful for fine-tuning treatment protocols for cholesteatoma and chronic OM in settings with limited health care resources.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      (Copyright © 2022 Frank, Magno, Velasco, Bootpetch, Salud, David, Miller, Yee, Dulnuan, Pyles, Lacuata, Arbizo, Kofonow, Guce, Mendoza, Robertson, Ilustre, Chiong, Lu, Tongol, Sacayan, Yarza, Chiong and Santos-Cortez.)
    • References:
      Front Cell Infect Microbiol. 2022 Jan 14;11:798246. (PMID: 35096646)
      Ear Nose Throat J. 2021 Nov;100(9):NP391-NP396. (PMID: 32352873)
      Biomed Res Int. 2015;2015:854024. (PMID: 25866816)
      Am J Otolaryngol. 2011 Jan-Feb;32(1):32-7. (PMID: 20036033)
      Rom J Morphol Embryol. 2014;55(1):7-13. (PMID: 24715159)
      Genome Res. 1998 Mar;8(3):175-85. (PMID: 9521921)
      J Infect Chemother. 2015 Jul;21(7):483-91. (PMID: 26004175)
      Laryngoscope. 2012 Nov;122(11):2568-73. (PMID: 23108885)
      Acta Otolaryngol. 2016;136(5):456-9. (PMID: 26881324)
      mSphere. 2019 Sep 4;4(5):. (PMID: 31484741)
      Microbiome. 2014 May 05;2:15. (PMID: 24910773)
      Otol Neurotol. 2007 Dec;28(8):1034-7. (PMID: 17921908)
      Int J Cancer. 1994 Nov 15;59(4):463-6. (PMID: 7960213)
      Int J Pediatr Otorhinolaryngol. 2015 Aug;79(8):1275-8. (PMID: 26115935)
      JAMA Intern Med. 2016 Dec 1;176(12):1870-1872. (PMID: 27775770)
      Int J Pediatr Otorhinolaryngol. 1995 Mar;31(2-3):153-7. (PMID: 7782173)
      Otolaryngol Head Neck Surg. 2018 Oct;159(4):724-732. (PMID: 29688828)
      Eur Arch Otorhinolaryngol. 2013 Feb;270(2):521-6. (PMID: 22566178)
      Bioinformatics. 2012 Jul 15;28(14):1823-9. (PMID: 22556368)
      Sci Rep. 2020 Sep 14;10(1):15035. (PMID: 32929111)
      Appl Environ Microbiol. 2011 May;77(10):3219-26. (PMID: 21421784)
      Ecol Lett. 2011 Jan;14(1):19-28. (PMID: 21070562)
      Braz J Otorhinolaryngol. 2017 Mar - Apr;83(2):126-131. (PMID: 27236633)
      Laryngoscope. 2017 Oct;127(10):E371-E377. (PMID: 28397271)
      JAMA. 2016 May 3;315(17):1864-73. (PMID: 27139059)
      Nucleic Acids Res. 2007;35(21):7188-96. (PMID: 17947321)
      Vaccine. 2018 Nov 26;36(49):7479-7486. (PMID: 30385056)
      Med J Aust. 2009 Nov 2;191(S9):S60-4. (PMID: 19883359)
      Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6. (PMID: 23193283)
      J Infect Chemother. 2020 Sep;26(9):890-899. (PMID: 32622623)
      Infect Dis Poverty. 2016 Nov 1;5(1):97. (PMID: 27799062)
      J Clin Microbiol. 2016 Oct;54(10):2538-46. (PMID: 27487953)
      Genome Res. 1998 Mar;8(3):186-94. (PMID: 9521922)
      Pediatrics. 2015 May;135(5):e1182-9. (PMID: 25896832)
      Int J Audiol. 2017 Feb;56(2):65-76. (PMID: 27841699)
      Otol Neurotol. 2019 Oct;40(9):1186-1193. (PMID: 31469791)
      mSystems. 2021 Apr 20;6(2):. (PMID: 33879499)
      JAMA Otolaryngol Head Neck Surg. 2017 Sep 1;143(9):928-934. (PMID: 28750130)
      Nat Methods. 2012 Mar 04;9(4):357-9. (PMID: 22388286)
      Acta Otorhinolaryngol Ital. 2009 Aug;29(4):197-202. (PMID: 20161877)
      J Paediatr Child Health. 2015 Apr;51(4):403-9. (PMID: 25303240)
      J Clin Microbiol. 2011 Dec;49(12):4083-8. (PMID: 21998418)
      Vet Dermatol. 2020 Dec;31(6):431-e114. (PMID: 32924232)
      Dev Sci. 2018 May;21(3):e12588. (PMID: 28880490)
      ORL J Otorhinolaryngol Relat Spec. 2007;69(4):251-5. (PMID: 17409785)
      Int J Pediatr Otorhinolaryngol. 2019 Mar;118:103-109. (PMID: 30599284)
      Pediatr Infect Dis J. 2017 Mar;36(3):342-344. (PMID: 27902646)
      Otol Neurotol. 2012 Jan;33(1):48-53. (PMID: 22143300)
      Ann Otol Rhinol Laryngol. 1972 Feb;81(1):1-11. (PMID: 5009814)
      Lancet. 2021 Mar 13;397(10278):996-1009. (PMID: 33714390)
      Proc Am Thorac Soc. 2011 Mar;8(1):90-100. (PMID: 21364226)
      Otol Neurotol. 2019 Jun;40(5):630-637. (PMID: 31083088)
      Arch Otolaryngol Head Neck Surg. 2002 Oct;128(10):1129-33. (PMID: 12365883)
      Cochrane Database Syst Rev. 2020 Jan 2;1:CD013051. (PMID: 31896168)
      PLoS One. 2014 Jan 23;9(1):e86397. (PMID: 24466073)
      Front Genet. 2020 Jan 17;10:1352. (PMID: 32010199)
      Am J Hum Genet. 2018 Nov 1;103(5):679-690. (PMID: 30401457)
      Curr Opin Pediatr. 2015 Feb;27(1):110-5. (PMID: 25514574)
      Bioinformatics. 2013 Dec 1;29(23):3100-1. (PMID: 24021386)
      PLoS One. 2013 Jul 02;8(7):e67019. (PMID: 23843979)
      Lancet. 2020 Oct 17;396(10258):1204-1222. (PMID: 33069326)
      J Med Genet. 2021 Jul;58(7):442-452. (PMID: 32709676)
      BMC Microbiol. 2018 Feb 20;18(1):13. (PMID: 29458340)
      Biofilm. 2021 Jan 06;3:100041. (PMID: 33665609)
      Anaerobe. 2015 Aug;34:120-4. (PMID: 25988544)
      Int J Pediatr Otorhinolaryngol. 2018 Nov;114:159-165. (PMID: 30262357)
      Bioinformatics. 2011 Aug 15;27(16):2194-200. (PMID: 21700674)
    • Grant Information:
      R01 DC015004 United States DC NIDCD NIH HHS
    • Contributed Indexing:
      Keywords: 16S rRNA; cholesteatoma; microbiome; middle ear; otitis media
    • Accession Number:
      0 (RNA, Ribosomal, 16S)
    • Publication Date:
      Date Created: 20220506 Date Completed: 20220509 Latest Revision: 20220716
    • Publication Date:
      20240829
    • Accession Number:
      PMC9063009
    • Accession Number:
      10.3389/fcimb.2022.746428
    • Accession Number:
      35521215